scholarly article | Q13442814 |
P356 | DOI | 10.1093/BRAIN/AWU363 |
P698 | PubMed publication ID | 25534356 |
P50 | author | Ruth L O'Gorman | Q37373470 |
Petra Susan Hüppi | Q55324568 | ||
Cornelia Hagmann | Q83280612 | ||
P2093 | author name string | Ulrike Held | |
Swiss EPO Neuroprotection Trial Group | |||
Brigitte M Koller | |||
Hans U Bucher | |||
P2860 | cites work | Advances in functional and structural MR image analysis and implementation as FSL | Q29547164 |
Fast robust automated brain extraction | Q29615078 | ||
Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data | Q29615647 | ||
Microstructural brain development after perinatal cerebral white matter injury assessed by diffusion tensor magnetic resonance imaging | Q30636036 | ||
Magnetic resonance techniques in the evaluation of the perinatal brain: recent advances and future directions. | Q30657669 | ||
Serial quantitative diffusion tensor MRI of the premature brain: development in newborns with and without injury | Q30749326 | ||
Diffusion-weighted imaging of the brain in preterm infants with focal and diffuse white matter abnormality | Q30808877 | ||
Diffusion tensor imaging with tract-based spatial statistics reveals local white matter abnormalities in preterm infants | Q31104655 | ||
Microstructural development of human newborn cerebral white matter assessed in vivo by diffusion tensor magnetic resonance imaging | Q31998758 | ||
Diffusion tensor imaging of brain development | Q33256938 | ||
Erythropoietin sustains cognitive function and brain volume after neonatal stroke | Q33492716 | ||
Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent age. | Q34041820 | ||
Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury | Q34056625 | ||
The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential | Q34199255 | ||
Extreme premature birth is not associated with impaired development of brain microstructure | Q34213182 | ||
Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models | Q34325318 | ||
A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. | Q34488111 | ||
Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia. | Q34592614 | ||
An overview of mortality and sequelae of preterm birth from infancy to adulthood | Q34738491 | ||
Multi-modal assessment of long-term erythropoietin treatment after neonatal hypoxic-ischemic injury in rat brain. | Q35154982 | ||
Sex differences in outcomes of very low birthweight infants: the newborn male disadvantage | Q35290150 | ||
Prognosis of the very low birthweight baby in relation to gender | Q35602941 | ||
Epo and other hematopoietic factors | Q36059793 | ||
Fractional anisotropy in white matter tracts of very-low-birth-weight infants | Q36143724 | ||
Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics | Q36277628 | ||
Erythropoietin: not just about erythropoiesis | Q36972360 | ||
Testing the sensitivity of Tract-Based Spatial Statistics to simulated treatment effects in preterm neonates | Q36981158 | ||
Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances | Q37253850 | ||
Neuroprotection in the newborn infant | Q37452432 | ||
Prediction of neurodevelopmental outcome after preterm birth | Q37477714 | ||
Neuroprotective role of erythropoietin in neonates | Q38041616 | ||
Nonrigid registration using free-form deformations: application to breast MR images | Q39512989 | ||
Neurodevelopmental outcome of prematurely born children treated with recombinant human erythropoietin in infancy | Q41721043 | ||
Erythropoietin increases neurogenesis and oligodendrogliosis of subventricular zone precursor cells after neonatal stroke | Q42267137 | ||
A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety | Q42664024 | ||
White matter changes in extremely preterm infants, a population-based diffusion tensor imaging study | Q43596293 | ||
An approach to using recombinant erythropoietin for neuroprotection in very preterm infants | Q43716045 | ||
Diffusion tensor imaging: serial quantitation of white matter tract maturity in premature newborns | Q44047062 | ||
Abnormal white matter signal on MR imaging is related to abnormal tissue microstructure | Q44286603 | ||
White matter microstructure is influenced by extremely preterm birth and neonatal respiratory factors. | Q44353793 | ||
Adult and neonatal human brain: diffusional anisotropy and myelination with diffusion-weighted MR imaging | Q44436009 | ||
Effect of antenatal growth on brain white matter maturation in preterm infants at term using tract-based spatial statistics. | Q45902744 | ||
Neonatal and infant outcome in boys and girls born very prematurely | Q46325267 | ||
Quantitative diffusion tensor MRI fiber tractography of sensorimotor white matter development in premature infants | Q46476482 | ||
Selective vulnerability of preterm white matter to oxidative damage defined by F2-isoprostanes | Q46571382 | ||
Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron | Q47402202 | ||
Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia | Q47884238 | ||
A comparison of high-dose recombinant erythropoietin treatment regimens in brain-injured neonatal rats | Q48161042 | ||
Tract-based spatial statistics of magnetic resonance images to assess disease and treatment effects in perinatal asphyxial encephalopathy | Q48177731 | ||
An optimised tract-based spatial statistics protocol for neonates: applications to prematurity and chronic lung disease | Q48182177 | ||
Erythropoietin is neuroprotective against NMDA-receptor-mediated excitotoxic brain injury in newborn mice. | Q48426321 | ||
Neonatal MRI to predict neurodevelopmental outcomes in preterm infants | Q48445305 | ||
Axial and radial diffusivity in preterm infants who have diffuse white matter changes on magnetic resonance imaging at term-equivalent age. | Q48665870 | ||
Neonatal tract-based spatial statistics findings and outcome in preterm infants | Q48841148 | ||
Pretreatment with low doses of erythropoietin ameliorates brain damage in periventricular leukomalacia by targeting late oligodendrocyte progenitors: a rat model | Q48930723 | ||
Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. | Q51878068 | ||
Gender differences in neurodevelopmental outcomes among extremely preterm, extremely-low-birthweight infants. | Q51912478 | ||
Diffusion Tensor Imaging in Preterm Infants With Punctate White Matter Lesions | Q57405356 | ||
P433 | issue | Pt 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | statistics | Q12483 |
erythropoietin | Q218706 | ||
preterm infant | Q45051448 | ||
spatial statistics | Q117467429 | ||
P304 | page(s) | 388-397 | |
P577 | publication date | 2014-12-22 | |
P1433 | published in | Brain | Q897386 |
P1476 | title | Tract-based spatial statistics to assess the neuroprotective effect of early erythropoietin on white matter development in preterm infants | |
P478 | volume | 138 |
Q36724697 | Accurate Learning with Few Atlases (ALFA): an algorithm for MRI neonatal brain extraction and comparison with 11 publicly available methods |
Q96763754 | Altered brain metabolism contributes to executive function deficits in school-aged children born very preterm |
Q52577385 | Chorioamnionitis, neuroinflammation, and injury: timing is key in the preterm ovine fetus. |
Q88691974 | Clinical Outcomes Related to the Gastrointestinal Trophic Effects of Erythropoietin in Preterm Neonates: A Systematic Review and Meta-Analysis |
Q38610168 | Controversies in preterm brain injury |
Q92877543 | Creative music therapy to promote brain function and brain structure in preterm infants: A randomized controlled pilot study |
Q42163693 | Creative music therapy to promote brain structure, function, and neurobehavioral outcomes in preterm infants: a randomized controlled pilot trial protocol |
Q51598694 | Differential short-term regional effects of early high dose erythropoietin on white matter in preterm lambs after mechanical ventilation. |
Q39297106 | Diffusion tensor imaging predicts motor outcome in children with acquired brain injury |
Q47176323 | Early erythropoiesis-stimulating agents in preterm or low birth weight infants |
Q89672648 | Early erythropoiesis-stimulating agents in preterm or low birth weight infants |
Q37347848 | Epigenomic profiling of preterm infants reveals DNA methylation differences at sites associated with neural function |
Q41160147 | Erythropoietin Protects Against Lipopolysaccharide-Induced Microgliosis and Abnormal Granule Cell Development in the Ovine Fetal Cerebellum |
Q41775024 | Erythropoietin Restores Long-Term Neurocognitive Function Involving Mechanisms of Neuronal Plasticity in a Model of Hyperoxia-Induced Preterm Brain Injury. |
Q28066377 | Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy |
Q55413545 | Extended Erythropoietin Treatment Prevents Chronic Executive Functional and Microstructural Deficits Following Early Severe Traumatic Brain Injury in Rats. |
Q47344689 | Impact of Erythropoiesis-Stimulating Agents on Behavioral Measures in Children Born Preterm. |
Q52310658 | Long-term neuroprotective effect of erythropoietin on executive functions in very preterm children (EpoKids): protocol of a prospective follow-up study. |
Q47216442 | Neonatal erythropoietin mitigates impaired gait, social interaction and diffusion tensor imaging abnormalities in a rat model of prenatal brain injury |
Q64096483 | Network based statistics reveals trophic and neuroprotective effect of early high dose erythropoetin on brain connectivity in very preterm infants |
Q47134409 | Neuroimaging in former preterm children who received erythropoiesis stimulating agents |
Q31071784 | Neuroprotective potential of erythropoietin in neonates; design of a randomized trial |
Q26786753 | New means to assess neonatal inflammatory brain injury |
Q48721304 | Partial white and grey matter protection with prolonged infusion of recombinant human erythropoietin after asphyxia in preterm fetal sheep. |
Q47366735 | Prenatal methadone exposure is associated with altered neonatal brain development |
Q36630778 | Preschool Assessment of Preterm Infants Treated With Darbepoetin and Erythropoietin |
Q30362400 | Probabilistic maps of the white matter tracts with known associated functions on the neonatal brain atlas: Application to evaluate longitudinal developmental trajectories in term-born and preterm-born infants |
Q89667013 | Recent advances in perinatal neuroprotection |
Q37375616 | Recombinant human erythropoietin improves neurological outcomes in very preterm infants |
Q99237677 | Repetitive Erythropoietin Treatment Improves Long-Term Neurocognitive Outcome by Attenuating Hyperoxia-Induced Hypomyelination in the Developing Brain |
Q53828021 | Repetitive Neonatal Erythropoietin and Melatonin Combinatorial Treatment Provides Sustained Repair of Functional Deficits in a Rat Model of Cerebral Palsy. |
Q41011963 | Systemic Lipopolysaccharide Administration-Induced Cognitive Impairments are Reversed by Erythropoietin Treatment in Mice |
Q64262590 | The Potential Role of Ferroptosis in Neonatal Brain Injury |
Q35759084 | Tract shape modeling detects changes associated with preterm birth and neuroprotective treatment effects |
Q36378391 | White matter injury in the preterm infant: pathology and mechanisms |
Search more.